These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4301974)

  • 1. A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.
    Wild TF; Brown F
    Arch Gesamte Virusforsch; 1968; 24(1):86-103. PubMed ID: 4301974
    [No Abstract]   [Full Text] [Related]  

  • 2. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.
    Fellowes ON
    J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068
    [No Abstract]   [Full Text] [Related]  

  • 4. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 5. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of foot-and-mouth disease virus with ethylenimine.
    Cunliffe HR
    Appl Microbiol; 1973 Nov; 26(5):747-50. PubMed ID: 4357652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunizing potency of a foot-and-mouth disease vaccine for cattle by treatment of the antigen with formaldehyde.
    Mowat GN; Masters RC; Prince MJ
    Arch Gesamte Virusforsch; 1973; 41(4):365-70. PubMed ID: 4354238
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1971 Oct; 13(1):85-93. PubMed ID: 4331815
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological behaviour & antigenicity of mouse passaged & formol inactivated foot & mouth disease virus type Asia-1 in guineapigs.
    Saraswat KC; Sharma KN; Mehrotra PN
    Indian J Exp Biol; 1980 Mar; 18(3):275-8. PubMed ID: 6248457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of gamma radiation on the infectivity, antigenicity and immunogenicity of the foot-and-mouth disease virus].
    Frescura T; Massa D; Cardaras P
    Boll Ist Sieroter Milan; 1972; 51(2):109-17. PubMed ID: 4345590
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization of guinea pigs with foot-and-mouth disease virus subjected to photodynamic inactivation.
    Espensen L
    Acta Pathol Microbiol Scand; 1966; 68(4):585-91. PubMed ID: 4289502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
    Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
    Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
    Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
    Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunochemical studies of foot-and-mouth disease. VII. Characterization of foot-and-mouth disease virus concentrated by polyethylene glycol precipitation.
    Wagner GG; Card JL; Cowan KM
    Arch Gesamte Virusforsch; 1970; 30(4):343-52. PubMed ID: 4318624
    [No Abstract]   [Full Text] [Related]  

  • 19. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physical chemical measurement of 140S particles of the foot-and-mouth disease virus].
    Fayet MT; Fargeaud D; Louisot P; Stellmann C; Roumiantzeff M
    Ann Inst Pasteur (Paris); 1971 Jul; 121(1):107-18. PubMed ID: 4329751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.